J&J Ordered To Pay South Carolina $327 Million For "Detestable" Risperdal Marketing
This article was originally published in The Pink Sheet Daily
Executive Summary
The award is based on the number of drug samples distributed and Dear Doctor letters issued; South Carolina just filed a similar suit against GlaxoSmithkline over its Avandia marketing.